How many investments has Spruce Capital Partners made?

Spruce Capital Partners has 12 tracked investments, including 1 dated in the last 24 months.

What stage does Spruce Capital Partners invest at?

Spruce Capital Partners invests at the Series A, Series B, Growth stages.

Where is Spruce Capital Partners located?

Spruce Capital Partners is headquartered in South San Francisco, US.

Who does Spruce Capital Partners co-invest with?

Spruce Capital Partners most often shares deals with Prelude Ventures, Breakthrough Energy Ventures, DCVC (Data Collective), among 29 tracked co-investors.

Spruce Capital Partners

Venture capitaloperating company · company profile

South San Francisco · Series A–Growth · 3 people tracked

Also known as SPRUCE CAPITAL PARTNERS LLC

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Spruce Capital Partners

228 people in our graph share verified history with the Spruce Capital Partners team — schools, employers, funds. One of them is your warm intro.

Johanunlockedknows Roger Wyse · together at Alliance VC (overlapped)

knows the team · via Alliance VC

×2knows the team · via Innovation Fund Denmark

×2knows the team · via Pivot Bio

knows the team · via Provivi

knows the team · via GreenLight Biosciences

✨ Fox Verdict

Investment thesis

Spruce Capital Partners focuses on the life sciences sector, backing companies that generate positive environmental impact while advancing human health and wellness. Beyond providing capital, the firm takes an active role by creating and advising companies, indicating a hands-on approach that spans company formation, guidance, and investment.

Invests inBiotech Climate Tech Digital Health Healthtech Medical Devices Wellness & Fitness South San Francisco United States

Source: firm website, verified Sep 15, 2026.

Stage

Series A–Growth

South San Francisco, California, US

Instruments

Equity

Founded

2013

Last 12 months

1 investment

Private fund assets

$116.6M

VC funds

Tracked investments

Team · 3 people

from the firm's website

Ganesh Kishore· Managing Partner· Singapore, Singaporein

Ganesh Kishore is a co-founder and Managing Partner at Spruce Capital Partners, with a background in biotechnology research, development, and business. He earned a Ph.D. in biochemistry from the Indian Institute of Science and completed postdoctoral training at the University of Texas at Austin. His earlier career included roles at Monsanto (where he contributed to Roundup Ready technology and Aspartame synthesis and led its Nutrition & Consumer Sector), Chief Technology Officer of Agriculture & Nutrition and later Chief Biotechnology Officer at DuPont, and CEO of the Malaysian Life Science Capital Fund.

k•••@sprucecp.comreveal

Roger Wyse· Managing Partner· Austin, Texas, United States

Roger Wyse is co-founder and Managing Partner at Spruce Capital Partners, which he helped launch in 2013. He previously spent time at Burrill & Company from 1998 to 2013, where he served as President and COO of Biogreentech and led its agriculture, food, nutraceuticals, and industrial biotech venture activities. His earlier career included roles as Dean of the College of Agricultural and Life Sciences at the University of Wisconsin-Madison, Dean of Research at Cook College at Rutgers University, and 15 years as a scientist with the USDA-ARS.

r•••@sprucecp.comreveal

Greg Young· Managing Partner

Greg Young is a Managing Partner and co-founder of Spruce Capital Partners, with over eighteen years of experience in biotechnology. He previously served as a Managing Director at Burrill & Company, a financial services firm focused on the life sciences, and earlier worked as a molecular biologist specializing in protein expression at a San Diego biotech startup. His investment focus includes agriculture, renewable energy, chemicals, and biological tools that support sustainability. He holds a BS in Biochemistry and Cell Biology from UC San Diego and an MS in Biotechnology from Northwestern University.

g•••@sprucecp.comreveal

What they invest in

from 10 of 12 portfolio companies

AgTech ×6Biotech ×6AI & Machine Learning ×2Healthtech ×2Climate Tech ×1Deep Tech ×1Digital Health ×1FemTech ×1

HQs:United States×8

Who they back

founder profiles across 6 portfolio companies

Where their founders studiedfrom 11 founders with education data

Caltech ×3University of California, Berkeley ×3Massachusetts Institute of Technology ×2Technion ×2

What their founders studiedfrom 11 founders with field-of-study data

Engineering ×5Life Sciences ×3

Investments · 12 tracked

founders shown can be your intro path

By year:2026 · 1 2023 · 1 2021 · 1 2015 · 14 dated

Infinant Healthinfinanthealth.com in 𝕏Jun 2026SEC filingmedium confidence

Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.

BiotechDigital HealthFemTechHealthtechWellness & FitnessSacramento, US

J. Bruce German(Co-founder)David Mills(Co-founder)inCarlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)inMichael Johnson(Executive Officer, Director)

Board seat Roger Wyse· per SEC Form D · $118.2M raise · filed Jun 2026

Co-investorsAcre Venture Partners Bow Capital Horizons Ventures iSelect Fund Longitude Capital Bill & Melinda Gates Foundation

Inscriptainscripta.comJun 2023

BiotechBoulder, US

Michael Graige(Executive Officer)Ron McGrath(Executive Officer)Sri Kosaraju(Executive Officer, Director)Dianna L. DeVore(Executive Officer)

Board Bryan Roberts(Director)in

Board seat Roger Wyse· per SEC Form D

Co-investorsForesite Capital iGlobe Partners Korys Oak HC/FT OMX Ventures Paladin Capital Group +3 more

AGERpointagerpoint.com in 𝕏

Agerpoint provides an AI-powered field intelligence platform that combines smartphone scans, LiDAR, satellite imagery, drones, sensors, and connected equipment data to analyze crops, trees, and field conditions in production agriculture.

AgTechAI & Machine LearningClimate TechOrlando, US

K. Thomas McPeek(Executive Officer, Director, Promoter)in Kevin Lang(CEO & President)in Michael Gomes(VP & GM, Intelligent Equipment)in Gary Rudolph(VP, Engineering)in Mike Batesole(CFO)in

Co-investorsBlackhorn Ventures Cultivation Capital

Consumer Physicsconsumerphysics.com in 𝕏

Consumer Physics (SCiO) makes a handheld near-infrared spectroscopy scanner paired with a database of molecular signatures to analyze the chemical composition of physical materials.

AgTechAI & Machine LearningDeep TechFoodTechHardwareHerzliya

Damian Goldring(Executive Officer)in Dror Sharon(Executive Officer, Director)inHaiyin Shen(Director)William Rosenzweig(Director)

BoardBenny Buller(Director)

Co-investorsXeraya Capital Khosla Ventures OurCrowd

Crop Enhancementcrop-enhancement.com

Crop Enhancement develops CropCoat, a nontoxic crop treatment that leaves no residue on the harvested crop, aimed at agricultural growers.

AgTechNew Materials

Co-investors1955 Capital Bandgap Ventures Phoenix Venture Partners

Evolve Biosystemsevolvebiosystems.com in 𝕏Jul 2015

Evolve Biosystems develops probiotic strains of B. infantis, including EVC001 and a next-generation drug strain INF108, aimed at supporting the infant gut microbiome and preventing necrotizing enterocolitis (NEC) in premature infants.

BiotechHealthtechMedical DevicesDavis, US

J. Bruce German(Director)David Mills(Executive Officer)in David J. Kyle(Executive Officer, Director)inJohn Campbell(Executive Officer)James Campbell(Executive Officer)in

BoardDaniel Janney(Director)

Co-investorsiSelect Fund Acre Venture Partners

GreenLight Biosciencesgreenlightbiosciences.com in

GreenLight Biosciences develops RNA-based solutions for agriculture and pest control, including a Colorado potato beetle bio-insecticide and a Varroa destructor mite-control product for sustainable food production.

AgTechBiotechImpact & Social GoodMedford, US

Andrey Zarur(Executive Officer, Director)inMarta Ortega-Valle(Executive Officer)inWilliam Blake(Executive Officer)in

BoardDavid Furneaux(Director)Jonathan Fleming(Director)James Swartz(Director)

Co-investorsFuture Ventures Lewis & Clark Ventures Prelude Ventures S2G Investments Baird Capital Continental Grain Company +1 more

Pivot Biopivotbio.com in 𝕏

Pivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics.

AgTechBiotechEmeryville, US

Alvin Tamsir(Executive Officer, Director)in Karsten Temme(Executive Officer, Director)in

Board Roger Wyse(Director)in John Hamer(Director)in Matt Ocko(Director)in

Co-investorsBreakthrough Energy Ventures Congruent Ventures DCVC (Data Collective)G2 Venture Partners K3 Ventures Manta Ray Ventures +5 more

Proviviprovivi.com in 𝕏

AgTechSanta Monica, US

Frances Arnold(Director)inPeter Meinhold(Executive Officer)in Pedro Coelho(Executive Officer)in Corey Huck(Executive Officer, Director)in

Board GANESH KISHORE(Director)inALAN BOYCE(Director)

Co-investorsAliment Capital Kairos Venture Investments, Llc Pontifax AgTech Vivo Capital Kairos Venture Partners Xeraya Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Amfora Inc.AmforaincMlscf

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

Agerpoint Awarded Meta AI Glasses Impact Grant to Advance Hands-Free Intelligence for Agricultural Fieldwork

AGERpoint · prnewswire.com · Jul 29, 2026

Infinant Health has filed a notice of an exempt offering of securities to raise $118,230,513.00 in New Funding. - intelligence360

Infinant Health · intelligence360.news · Jul 21, 2026

Pivot Bio Celebrates America 250 with Patriotic Brand Takeover and Summer of Gratitude | Pivot Bio

Pivot Bio · pivotbio.com · Jul 1, 2026

Trysignalbase

Provivi · trysignalbase.com · Jun 11, 2026

Striving to Commercialize CRISPR, Inscripta Lands $55M | Chief Healthcare Executive

Inscripta · chiefhealthcareexecutive.com · Jan 8, 2026

Frequently asked questions

How many investments has Spruce Capital Partners made?: Spruce Capital Partners has 12 tracked investments, including 1 dated in the last 24 months.
What stage does Spruce Capital Partners invest at?: Spruce Capital Partners invests at the Series A, Series B, Growth stages.
What sectors does Spruce Capital Partners focus on?: Spruce Capital Partners focuses on Biotech, Climate Tech, Digital Health, Healthtech, Medical Devices, Wellness & Fitness.
Where is Spruce Capital Partners located?: Spruce Capital Partners is headquartered in South San Francisco, US.
Who does Spruce Capital Partners co-invest with?: Spruce Capital Partners most often shares deals with Prelude Ventures, Breakthrough Energy Ventures, DCVC (Data Collective), among 29 tracked co-investors.

Images

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

$100K – $10M

Kfund

Kfund is a venture capital firm that invests in entrepreneurs building differentiated technology-based products and services.

$108K – $10.8M

Brookstreet Equity Partners

Brookstreet Equity Partners LLP is a family-office-originated GP established by shipping and principal-capital families, operating as an institutional investment manager focused on AI-driven investments across digital transformation, energy transition, longevity, and defence technology.

JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.

$100K – $20M